SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

DSpace/Manakin Repository

SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines

Citable link to this page

. . . . . .

Title: SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines
Author: Demichelis, Francesca; Macoska, Jill A.; Sellers, William R.; Rubin, Mark A.; Greulich, Heidi E.; Beroukhim, Rameen; Garraway, Levi Alexander

Note: Order does not necessarily reflect citation order of authors.

Citation: Demichelis, Francesca, Heidi Greulich, Jill A. Macoska, Rameen Beroukhim, William R. Sellers, Levi Garraway, and Mark A. Rubin. 2008. SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines. Nucleic Acids Research 36(7): 2446-2456.
Full Text & Related Files:
Abstract: Translational research hinges on the ability to make observations in model systems and to implement those findings into clinical applications, such as the development of diagnostic tools or targeted therapeutics. Tumor cell lines are commonly used to model carcinogenesis. The same tumor cell line can be simultaneously studied in multiple research laboratories throughout the world, theoretically generating results that are directly comparable. One important assumption in this paradigm is that researchers are working with the same cells. However, recent work using high throughput genomic analyses questions the accuracy of this assumption. Observations by our group and others suggest that experiments reported in the scientific literature may contain pre-analytic errors due to inaccurate identities of the cell lines employed. To address this problem, we developed a simple approach that enables an accurate determination of cell line identity by genotyping 34 single nucleotide polymorphisms (SNPs). Here, we describe the empirical development of a SNP panel identification assay (SPIA) compatible with routine use in the laboratory setting to ensure the identity of tumor cell lines and human tumor samples throughout the course of long term research use.
Published Version: doi:10.1093/nar/gkn089
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367734/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4853413

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters